Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Construction in Progress (2017 - 2020)

Champions Oncology (CSBR) has 4 years of Construction in Progress data on record, last reported at $441000.0 in Q4 2020.

  • For Q4 2020, Construction in Progress changed N/A year-over-year to $441000.0; the TTM value through Oct 2020 reached $441000.0, changed N/A, while the annual FY2020 figure was $554000.0, 3362.5% up from the prior year.
  • Construction in Progress reached $441000.0 in Q4 2020 per CSBR's latest filing, up from $114000.0 in the prior quarter.
  • Across five years, Construction in Progress topped out at $619000.0 in Q3 2019 and bottomed at $15000.0 in Q2 2018.
  • Average Construction in Progress over 4 years is $196076.9, with a median of $58000.0 recorded in 2018.
  • Peak YoY movement for Construction in Progress: plummeted 96.82% in 2018, then skyrocketed 3362.5% in 2020.
  • A 4-year view of Construction in Progress shows it stood at $19000.0 in 2017, then skyrocketed by 31.58% to $25000.0 in 2018, then surged by 2376.0% to $619000.0 in 2019, then fell by 28.76% to $441000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Construction in Progress were $441000.0 in Q4 2020, $114000.0 in Q3 2020, and $554000.0 in Q2 2020.